Last reviewed · How we verify
NCT05199246: Exo-KGO1
Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
NA trial testing Lower-limb powered dermoskeleton in Muscular Dystrophies in 50 participants. Completed in 22 April 2025.
22 April 2025
Quick facts
| Lead sponsor | Institut de Myologie, France |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 1 December 2021 |
| Primary completion | 22 April 2025 |
| Estimated completion | 22 April 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Lower-limb powered dermoskeleton
Conditions studied
- Muscular Dystrophies — all drugs for Muscular Dystrophies →
- Congenital Myopathy — all drugs for Congenital Myopathy →
- Idiopathic Inflammatory Myopathies — all drugs for Idiopathic Inflammatory Myopathies →
- Mitochondrial Myopathies — all drugs for Mitochondrial Myopathies →
Sponsor
Institut de Myologie, France — full company profile →
Who can join
Adults 18 to 70, any sex, with Muscular Dystrophies or Congenital Myopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of the current study are as follow: i) Evaluate the safety, usability, and acute efficiency of a programmable ambulation exoskeleton (KeeogoTM Dermoskeleton System, B-Temia Inc., Quebec, Canada) in patients with neuromuscular disorders, ii) Elaborate recommendations regarding usability criteria for safe and efficient use the device in patients with neuromuscular disorders (e.g. type and severity of patient's functional deficits), iii) generate necessary data to foresee a future study involving a home use of the device and assessment of long-term benefits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05199246
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscular Dystrophies
Currently open trials in the same condition.
- NCT07287189 — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients · Phase 2 · recruiting
- NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
- NCT06378203 — Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI] · NA · recruiting
- NCT06094205 — Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) · NA · recruiting
- NCT06924125 — Spanish Natural History Study for LAMA2 Muscular Dystrophy · recruiting
Other Institut de Myologie, France trials
Trials by the same sponsor.
- NCT07321977 — Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular D · NA · recruiting
- NCT07321990 — Study of the Reproducibility of the French Version of the Modified SMAFRS Scale · recruiting
- NCT06354790 — Natural History Study of Children With LAMA2-related Dystrophies · recruiting
- NCT05839145 — Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study · NA · unknown
- NCT05798325 — Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Li · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05199246 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut de Myologie, France
- Last refreshed: 16 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05199246.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing